21. Safety and Efficacy of the Cd95-Ligand Inhibitor Asunercept in Transfusion-Dependent Patients with Low and Intermediate Risk MDS. (April 2017) Authors: Boch, T.; Luft, T.; Mossner, M.; Jann, J.C.; Nowak, D.; Schumann, C.; Klemmer, J.; Brendel, S.; Fricke, H.; Kunz, C.; Hofmann, W.K.; Nolte, F. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. The oral bioavailability of di-2-ethylhexyl phthalate (DEHP), di-isononyl phthalate (DiNP) and di-(isononyl)-cyclohexane-1, 2-dicarboxylate (DINCH®) in house dust. (1st February 2022) Authors: Plichta, V.; Völkel, W.; Fembacher, L.; Wöckner, M.; Nowak, D.; Fromme, H. Journal: Toxicology letters Issue: Volume 355(2022) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Topic: AS04-MDS Biology and Pathogenesis/AS04c-MDS Mouse models (GEMMS, PDX): OPTIMIZATION OF MDS PATIENT-DERIVED XENOGRAFT (PDX) MODELS BY COMPARISON OF NSG AND NBSGW MICE. (May 2023) Authors: Schmitt, N.; Streuer, A.; Danner, J.; Altrock, E.; Riabov, V.; Xu, Q.; Rapp, F.; Weimer, N.; Palme, I.; Nowak, V.; Obländer, J.; Göl, M.; Darwich, A.; Steiner, L.; Boch, T.; Jawhar, M.; Metzgeroth, G.; Hofmann, W.-K.; Nowak, D. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: BONE MARROW DERIVED STROMAL CELLS FROM MYELODYSPLASTIC SYNDROMES ARE ALTERED BUT NOT CLONALLY MUTATED IN VIVO. (September 2021) Authors: Jann, J.-C.; Mossner, M.; Flach, J.; Altrock, E.; Schmitt, N.; Ryabov, V.; Xu, Q.; Nowak, V.; Obländer, J.; Palme, I.; Weimer, N.; Streuer, A.; Jawhar, A.; Darwich, A.; Metzgeroth, G.; Nolte, F.; Hofmann, W.-K.; Nowak, D. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS. (May 2023) Authors: Ryabov, V.; Xu, Q.; Schmitt, N.; Streuer, A.; Ge, G.; Bolanos, L.; Wunderlich, M.; Jann, J.-C.; Wein, A.; Altrock, E.; Mukherjee, S.; Ali, A.M.; Rapp, F.; Nowak, V.; Weimer, N.; Obländer, J.; Palme, I.; Göl, M.; Jawhar, A.; Darwich, A. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Topic: AS08-Treatment/AS08e-New developments - Preclinical studies: A PRE-CLINICAL PATIENT-DERIVED XENOGRAFT MODEL OF MYELODYSPLASTIC SYNDROMES DEMONSTRATES EFFICACY AND SAFETY OF ELTROMBOPAG. (September 2021) Authors: Schmitt, N.; Jann, J.-C.; Altrock, E.; Flach, J.; Danner, J.; Uhlig, S.; Streuer, A.; Knaflic, A.; Riabov, V.; Xu, Q.; Mehralivand, A.; Palme, I.; Nowak, V.; Oblaender, J.; Weimer, N.; Haselmann, V.; Jawhar, A.; Darwich, A.; Weis, C.-A.; Marx, A. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Transcriptomic Changes upon Ageing of Bone Marrow Derived Mesenchymal Stromal Cells and Onset of MDS. (April 2017) Authors: Jann, J.C.; Mossner, M.; Nolte, F.; Boch, T.; Nowak, V.; Palme, I.; Obländer, J.; Pressler, J.; Xanthopoulos, C.; Röhl, H.; Hofmann, W.K.; Nowak, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗